A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

NCT05115019 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Decrease of incidence and severity of COVID and availability of therapeutic alternatives

Conditions

Interventions

Sponsor

PT. Innovative Pharma Solutions

Collaborators